Among the medical-imaging patents issued the week of April 28, 2026, one assignee appeared more than any other. The patent record's assignee breakdown for the week shows GE Precision Healthcare — the legal entity behind the GE HealthCare imaging business — with six granted patents, more than twice the count of the next names on the list, Nvidia and Koninklijke Philips. For a reader tracking the imaging-hardware market, the week's grants are a snapshot of where one of its largest players is converting research into enforceable coverage.

The lead grant, US12615860B2, is titled "X-ray detector with rectangular pixels." Its abstract describes a flat-panel detector design that can change its effective resolution on the fly depending on the imaging task — energizing pixel pairs together for low-dose work and sequentially for high-dose work.

In low-dose applications, TFT control lines of pixels in each pixel pair are energized simultaneously to generate signals with an effective pixel pitch of twice the rectangular pixel pitch and in high-dose applications, TFT control lines of pixels in each pixel pair are energized sequentially and the detector is translated during image acquisition for an effective pixel pitch of half the rectangular pixel pitch.— X-ray detector with rectangular pixels, US12615860B2

The week's grants in context

The detector grant was not the only imaging-hardware patent GE locked in that week. US12614326B2, issued the same day, claims "scatter and tailing correction" for nuclear-medicine imaging — a reconstruction technique applied after the raw photon data is captured. Pairing a detector-hardware grant with a reconstruction-software grant in a single week is consistent with a company filing across the full imaging chain, from the sensor to the image.

That pattern holds across the broader estate. A search of the patent record returns more than 1,100 granted U.S. patents assigned to GE Precision Healthcare. Recent issuances illustrate the breadth: US12650393B2 covers "material weighting of projection based spectral x-ray imaging" for CT; US12657798B2 claims image reconstruction "based on energy-resolved x-ray data"; and US12660073B2 and US12653467B2 cover the X-ray tube and its flat emitter assembly. The estate also reaches into ultrasound: US12648759B2 claims a contrast-enhanced ultrasonic examination device.

Where the coverage concentrates

By classification, the estate skews toward image processing and the modalities GE is known for. The most common CPC code across its grants is G06T 7/0012 (image analysis for medical purposes), on 166 patents, followed by the CT code A61B 6/032 on 107 and the MRI code A61B 5/055 on 76. The issued-by-year counts show a sustained build: 218 grants indexed in 2023, 282 in 2024, and 177 so far in the current year.

For a general business reader, the week's batch describes coverage, not conclusions. GE added six imaging patents in a single week — led by a configurable X-ray detector — to an estate already numbering in the four figures and weighted toward detectors, tubes, CT and MRI hardware, and the reconstruction software that turns their output into images. Granted claims are enforceable coverage, and the week's grants extend GE's across the parts of the imaging system its products are built around. The records show a continuing, broad-based filing program rather than a pivot; the new patents widen an already-wide footprint.